Table 7 Clinical outcomes and response to initial therapy at one year of follow-up
Clinical outcomes at one year of follow up | N = 2013 | |
|---|---|---|
Achieved serum TSH target values | Â | 1236 (61.4) |
| Â | Thyroidectomy with RAI (n = 982) | 635 (64.7) |
| Â | Thyroidectomy without RAI (n = 1031) | 601 (58.3) |
| Â | Total/near-total thyroidectomy (n = 1672) | 1055 (63.1) |
| Â | Lobectomy (n = 202) | 110 (54.5) |
| Â | Intermediate risk (n = 1528) | 921 (60.3) |
| Â | High risk (n = 485) | 315 (64.9) |
Recurrence rate at 1-year follow-up | Total (n = 2013) | 27 (1.3) |
TSH achieved target values | Yes (n = 1236) | 16 (1.3) |
No (n = 693) | 11 (1.6) | |
Unknown (n = 84) | 0 | |
Recurrence risk stratification | Intermediate risk (n = 1528) | 19 (1.2) |
High risk (n = 485) | 11 (1.6) | |
Response to initial therapy for patients with total thyroidectomy and RAI ablation at one year of follow-up | N = 966 | |
| Â | Unknown | 147 (15.2) |
Data available | 819 (84.8) | |
Excellent | 258 (31.5) | |
Biochemical incomplete | 56 (6.8) | |
Structural incomplete | 88 (10.7) | |
Indeterminate | 417 (50.9) | |